R. Bornstein

Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22.

D. Wickerham, N. Wolmark, F. Meyers, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chronic myelogenous leukemia presenting in blastic crisis

B. Kennedy, M. Nesbit, R. Bornstein, 1972, Cancer.

An evaluation of the mechanism of action of pentamidine isethionate

J. Yarbro, R. Bornstein, 1970, Journal of surgical oncology.

Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer: 5-year results from the National Surgical Adjuvant Breast and Bowel Project Trial.

C. Redmond, N. Wolmark, B. Fisher, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intralesional BCG in the treatment of metastatic malignant melanoma

M. Mastrangelo, R. Prehn, J. Yarbro, 1976, Cancer.

Comparison of serum concentrations of methotrexate after various routes of administration

P. Engstrom, R. Bornstein, R. Bornstein, 1975, Cancer.

Breast involvement in acute lymphatic leukemia. Daunorubicine‐induced remission; pneumocystis carinii pneumonia

R. Bornstein, B. Kennedy, R. Brunning, 1970, Cancer.

The efficacy of recombinant human granulocyte colony-stimulating factor and recombinant human granulocyte macrophage colony-stimulating factor in permitting the administration of higher doses of cyclophosphamide in a doxorubicin-cyclophosphamide combination. An NSABP pilot study in patients with met

D. Wickerham, A. Glass, H. Bear, 1994, American journal of clinical oncology.

Long-term tamoxifen citrate use and potential ocular toxicity.

C. Redmond, J. Costantino, N. Wolmark, 1998, American journal of ophthalmology.

Breast Cancer Survival and in Vitro Tumor Response in the Extreme Drug Resistance Assay

C. McLaren, R. Parker, I. Yu, 2001, Breast Cancer Research and Treatment.